These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25230018)

  • 41. Lobular Histology Does Not Predict the Need for Axillary Dissection Among ACOSOG Z0011-Eligible Breast Cancers.
    Mamtani A; Zabor EC; Stempel M; Morrow M
    Ann Surg Oncol; 2019 Oct; 26(10):3269-3274. PubMed ID: 31342363
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histopathologcial and clonal study of combined lobular and ductal carcinoma of the breast.
    Tazaki E; Shishido-Hara Y; Mizutani N; Nomura S; Isaka H; Ito H; Imi K; Imoto S; Kamma H
    Pathol Int; 2013 Jun; 63(6):297-304. PubMed ID: 23782331
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic and biomarker analysis of invasive pleomorphic lobular carcinoma as compared with invasive classic lobular carcinoma: an experience in our institution and review of the literature.
    Jacobs M; Fan F; Tawfik O
    Ann Diagn Pathol; 2012 Jun; 16(3):185-9. PubMed ID: 22197540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Androgens in human breast carcinoma.
    Suzuki T; Miki Y; Takagi K; Hirakawa H; Moriya T; Ohuchi N; Sasano H
    Med Mol Morphol; 2010 Jun; 43(2):75-81. PubMed ID: 20683693
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.
    Rakha EA; El-Sayed ME; Powe DG; Green AR; Habashy H; Grainge MJ; Robertson JF; Blamey R; Gee J; Nicholson RI; Lee AH; Ellis IO
    Eur J Cancer; 2008 Jan; 44(1):73-83. PubMed ID: 18035533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of Lipid Metabolism-Related Proteins Differs between Invasive Lobular Carcinoma and Invasive Ductal Carcinoma.
    Cha YJ; Kim HM; Koo JS
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124996
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EZH2 expression in invasive lobular carcinoma of the breast.
    Roh S; Park SY; Ko HS; Sohn JS; Cha EJ
    World J Surg Oncol; 2013 Nov; 11():299. PubMed ID: 24266940
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.
    Da Ros L; Moretti A; Querzoli P; Pedriali M; Lupini L; Bassi C; Carcoforo P; Negrini M; Frassoldati A
    Clin Breast Cancer; 2018 Oct; 18(5):e1133-e1139. PubMed ID: 29759595
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Strong adverse effect of epidermal growth factor receptor 2 overexpression on prognosis of patients with invasive lobular breast cancer: a comparative study with invasive ductal breast cancer in Chinese population.
    Wang T; Ma Y; Wang L; Liu H; Chen M; Niu R
    Tumour Biol; 2015 Aug; 36(8):6113-24. PubMed ID: 25804795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.
    Jung SY; Jeong J; Shin SH; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
    BMC Cancer; 2010 Dec; 10():664. PubMed ID: 21126378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.
    Arps DP; Jorns JM; Zhao L; Bensenhaver J; Kleer CG; Pang JC
    Ann Surg Oncol; 2014 Dec; 21(13):4152-8. PubMed ID: 24980090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Androgens enhance the ability of intratumoral macrophages to promote breast cancer progression.
    Yamaguchi M; Takagi K; Sato M; Sato A; Miki Y; Onodera Y; Miyashita M; Sasano H; Suzuki T
    Oncol Rep; 2021 Sep; 46(3):. PubMed ID: 34278480
    [TBL] [Abstract][Full Text] [Related]  

  • 54. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures.
    Tasdemir N; Bossart EA; Li Z; Zhu L; Sikora MJ; Levine KM; Jacobsen BM; Tseng GC; Davidson NE; Oesterreich S
    Cancer Res; 2018 Nov; 78(21):6209-6222. PubMed ID: 30228172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology.
    Rakha EA; Gill MS; El-Sayed ME; Khan MM; Hodi Z; Blamey RW; Evans AJ; Lee AH; Ellis IO
    Breast Cancer Res Treat; 2009 Mar; 114(2):243-50. PubMed ID: 18404368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer.
    McNamara KM; Oguro S; Omata F; Kikuchi K; Guestini F; Suzuki K; Yang Y; Abe E; Hirakawa H; Brown KA; Takanori I; Ohuchi N; Sasano H
    Breast Cancer Res Treat; 2017 Jan; 161(2):213-227. PubMed ID: 27848152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.
    Vermeulen JF; van de Ven RA; Ercan C; van der Groep P; van der Wall E; Bult P; Christgen M; Lehmann U; Daniel J; van Diest PJ; Derksen PW
    PLoS One; 2012; 7(5):e37864. PubMed ID: 22662240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Invasive lobular carcinoma: to grade or not to grade.
    Bane AL; Tjan S; Parkes RK; Andrulis I; O'Malley FP
    Mod Pathol; 2005 May; 18(5):621-8. PubMed ID: 15605082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
    Bharat A; Gao F; Margenthaler JA
    Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.